Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Lei Wang, Qiao Ke, Kongying Lin, Jingbo Chen, Ren Wang, Chunhong Xiao, Xiaolong Liu & Jingfeng Liu. (2020) Not All Hepatocellular Carcinoma Patients with Microvascular Invasion After R0 Resection Could Be Benefited from Prophylactic Transarterial Chemoembolization: A Propensity Score Matching Study. Cancer Management and Research 12, pages 3815-3825.
Read now
Read now
Shi-Dong Lu, Lin Li, Xin-Min Liang, Wu Chen, Fu-Li Chen, Lang-Lin Fan, Bhavesh K. Ahir, Wan-Guang Zhang & Jian-Hong Zhong. (2019) Updates and advancements in the management of hepatocellular carcinoma patients after hepatectomy. Expert Review of Gastroenterology & Hepatology 13:11, pages 1077-1088.
Read now
Read now
Lei Wang, Qiao Ke, Manjun Deng, Xin Huang, Jianxing Zeng, Hongzhi Liu, Yuan Yang, Yongyi Zeng, Weiping Zhou & Jingfeng Liu. (2019) Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma after radical hepatectomy: a real world study. Scandinavian Journal of Gastroenterology 54:11, pages 1403-1411.
Read now
Read now
Articles from other publishers (19)
Yongzhu He, Junlin Qian, Guoqing Zhu, Zhao Wu, Lifeng Cui, Shuju Tu, Laihui Luo, Renfeng Shan, Liping Liu, Wei Shen, Yong Li & Kun He. (2024) Development and validation of nomograms to evaluate the survival outcome of HCC patients undergoing selective postoperative adjuvant TACE. La radiologia medica 129:4, pages 653-664.
Crossref
Crossref
海龙 尹. (2024) Study on the Related Factors of Hepatocellular Carcinoma with Microvascular Invasion. Journal of Clinical Personalized Medicine 03:01, pages 152-159.
Crossref
Crossref
Cailing Xiang, Xianbo Shen, Xinxin Zeng, Yuzhong Zhang, Zhongzhi Ma, Guocan Zhang, Xin Song, Tao Huang & Juan Yang. (2024) Effect of transarterial chemoembolization as postoperative adjuvant therapy for intermediate-stage hepatocellular carcinoma with microvascular invasion: a multicenter cohort study. International Journal of Surgery 110:1, pages 315-323.
Crossref
Crossref
Wei-Yue Chen, Chao Li, Zhi-Peng Liu, Qing-Yu Kong, Li-Yang Sun, Yong-Yi Zeng, Ying-Jian Liang, Ya-Hao Zhou, Ting-Hao Chen, Zi-Xiang Chen, Ming-Da Wang, Lan-Qing Yao, Wan Yee Lau, Timothy M Pawlik, Feng Shen, Jian-Song Ji & Tian Yang. (2023) Novel online calculator to predict reduced risk of early recurrence from adjuvant transarterial chemoembolisation for patients with hepatocellular carcinoma. eGastroenterology 1:1, pages e100008.
Crossref
Crossref
Zhi-Xi Li, Qi-Fan Zhang, Jia-Ming Huang, Shao-Jian Huang, Han-Biao Liang, Hao Chen, Zhan-Hong Lai, Qing-Yan Li, Jian-Ping Qian, Kai Wang & Jie Zhou. (2023) Safety and efficacy of postoperative adjuvant therapy with atezolizumab and bevacizumab after radical resection of hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 47:7, pages 102165.
Crossref
Crossref
Xiao-Hui Wang, Qun-Fang Zhou, Chen-Meng Wang, Cai-Ling Xiang, Ying-Hui Song, Shao-Qiang Li, Min-Shan Chen, Shuang-Lin Xiang, Chang-Jun Liu & Xian-Hai Mao. (2023) Adjuvant transarterial chemoembolization for intermediate-stage hepatocellular carcinoma with microvascular invasion. British Journal of Surgery 110:8, pages 913-916.
Crossref
Crossref
Long-Hai Feng, Yu-Yao Zhu, Jia-Min Zhou, Miao Wang, Wei-Qi Xu, Ti Zhang, An-Rong Mao, Wen-Ming Cong, Hui Dong & Lu Wang. (2023) Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy. Frontiers in Oncology 13.
Crossref
Crossref
Jiang Li, Fan Yang, Jian Li, Zhi-Yong Huang, Qi Cheng & Er-Lei Zhang. (2023) Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion. World Journal of Gastrointestinal Surgery 15:1, pages 19-31.
Crossref
Crossref
Cody R Criss & Mina S Makary. (2023) Salvage locoregional therapies for recurrent hepatocellular carcinoma. World Journal of Gastroenterology 29:3, pages 413-424.
Crossref
Crossref
Tao He, Jieyu Zou, Ke Sun, Juan Yang, Tingting Lei, Lin Xu, Jinheng Liu, Sineng Yin & Guangkuo Li. (2022) Global research status and frontiers on microvascular invasion of hepatocellular carcinoma: A bibliometric and visualized analysis. Frontiers in Oncology 12.
Crossref
Crossref
Nanping Lin, Lei Wang, Qizhen Huang, Weiping Zhou, Xiaolong Liu & Jingfeng Liu. (2022) A simplified model for prophylactic transarterial chemoembolization after resection for patients with hepatocellular carcinoma. PLOS ONE 17:10, pages e0276627.
Crossref
Crossref
Yiwen Qiu, Yi Yang, Tao Wang, Shu Shen & Wentao Wang. (2022) Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients With Microscopic Portal Vein Invasion. Frontiers in Oncology 12.
Crossref
Crossref
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Ying-Yi Qin, Wei-Jun Wang, Xiu-Ping Zhang, Yi-Tao Zheng, Yun-Feng Shan, Wen-Ming Cong, Hui Dong, Wan Yee Lau & Shu-Qun Cheng. (2022) A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasion. European Journal of Surgical Oncology 48:6, pages 1348-1355.
Crossref
Crossref
Lei Liang, Chao Li, Ming-Da Wang, Hong Wang, Ya-Hao Zhou, Yong-Yi Zeng, Wan-Guang Zhang, Ting-Hao Chen, Nan-Ya Wang, Jie Li, Yao-Ming Zhang, Yu Wang, Wei-Min Gu, Hao Xing, Yong-Kang Diao, Wan Yee Lau, Cheng-Wu Zhang, Timothy M. Pawlik, Feng Shen, Dong-Sheng Huang & Tian Yang. (2021) Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma. Journal of Hematology & Oncology 14:1.
Crossref
Crossref
Yifan Chen, Hongzhi Liu, Jinyu Zhang, Yijun Wu, Weiping Zhou, Zhangjun Cheng, Jianying Lou, Shuguo Zheng, Xinyu Bi, Jianming Wang, Wei Guo, Fuyu Li, Jian Wang, Yamin Zheng, Jingdong Li, Shi Cheng, Yongyi Zeng & Jingfeng Liu. (2021) Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China. BMC Cancer 21:1.
Crossref
Crossref
Qiao Ke, Fu Xiang, Chunhong Xiao, Qizhen Huang, Xiaolong Liu, Yongyi Zeng, Lei Wang & Jingfeng Liu. (2021) Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization. BMC Cancer 21:1.
Crossref
Crossref
Stepan M. Esagian, Christos D. Kakos, Emmanouil Giorgakis, Lyle Burdine, J. Camilo Barreto & Michail N. Mavros. (2021) Adjuvant Transarterial Chemoembolization Following Curative-Intent Hepatectomy Versus Hepatectomy Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cancers 13:12, pages 2984.
Crossref
Crossref
Lei Wang, Chunhong Xiao, Ren Wang, Jingbo Chen, Weiping Zhou, Jingfeng Liu, Nanping Lin & Kongying Lin. (2021) The Clinical Value of Postoperative Transarterial Chemoembolization for Resectable Patients with Intermediate Hepatocellular Carcinoma After Radical Hepatectomy: a Propensity Score-Matching Study. Journal of Gastrointestinal Surgery 25:5, pages 1172-1183.
Crossref
Crossref
Wentao Wang, Yaxun Guo, Jingtao Zhong, Qi Wang, Xin Wang, Honglong Wei, Jie Li & Peng Xiu. (2021) The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma. Scientific Reports 11:1.
Crossref
Crossref